Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-061835
Filing Date
2013-11-14
Accepted
2013-11-14 16:13:29
Documents
9
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v358889_10q.htm 10-Q 679026
2 EXHIBIT 31.1 v358889_ex31-1.htm EX-31.1 12322
3 EXHIBIT 32.1 v358889_ex32-1.htm EX-32.1 6187
  Complete submission text file 0001144204-13-061835.txt   3232884

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT immd-20130930.xml EX-101.INS 400578
5 XBRL TAXONOMY EXTENSION SCHEMA immd-20130930.xsd EX-101.SCH 28345
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE immd-20130930_cal.xml EX-101.CAL 26348
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE immd-20130930_def.xml EX-101.DEF 133288
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE immd-20130930_lab.xml EX-101.LAB 182308
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immd-20130930_pre.xml EX-101.PRE 164130
Mailing Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549
Business Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549 (914) 244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

EIN.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-184487 | Film No.: 131220064
SIC: 2833 Medicinal Chemicals & Botanical Products